physostigmine has been researched along with Brain Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levin, V; Prados, M; Rodriguez, L; Seager, M; Silver, P | 1 |
| Cognazzo, A; Fabiani, A; Monticone, GF; Schiffer, D | 1 |
| Flodmark, S | 1 |
3 other study(ies) available for physostigmine and Brain Neoplasms
| Article | Year |
|---|---|
Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas.
Topics: Adult; Brain Neoplasms; Diagnosis-Related Groups; Drug Evaluation; Female; Glioma; Humans; Hydantoins; Male; Middle Aged; Nitrogen Mustard Compounds; Physostigmine | 1987 |
Non-specific esterase in cerebral tumors. A histochemical study.
Topics: Acid Phosphatase; Astrocytoma; Brain Chemistry; Brain Neoplasms; Cytoplasm; Ependymoma; Esterases; Glioblastoma; Histocytochemistry; Humans; Lymphoma, Large B-Cell, Diffuse; Medulloblastoma; Neoplasm Metastasis; Neurilemmoma; Phosphates; Physostigmine | 1968 |
Clinical detection of blood-brain barrier alteration by means of EEG. I. EEG effects induced by two anticholinesterase agents--the lipid-soluble physostigmine and the lipid-insoluble neostigmine--on two different types of focal cerebral lesion in man.
Topics: Adult; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Electroencephalography; Epilepsy, Post-Traumatic; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neostigmine; Physostigmine | 1965 |